Enfeksiyon Hastalıkları

Authors

Gülsün Çavdar
Şükran Köse

Synopsis

This text comprehensively examines infectious diseases frequently encountered in family medicine, including meningitis, encephalitis, tetanus, rabies, gastroenteritis, viral hepatitis, and HIV. Meningitis presents with headache, fever, and meningismus caused by bacterial, viral, fungal, or protozoal agents, and its definitive diagnosis relies on cerebrospinal fluid (CSF) analysis. Encephalitis is an inflammation of the central nervous system, predominantly caused by viruses, resulting in altered consciousness and neurological deficits. Tetanus is a fatal infection caused by the exotoxin of Clostridium tetani, characterized by muscle spasms and rigidity, which is preventable via the Td vaccine. Rabies is a deadly zoonotic disease transmitted through infected animal bites, making post-exposure prophylaxis with vaccines and immunoglobulins critically essential. Gastroenteritis, caused by bacteria, viruses, or parasites, manifests as diarrhea that can lead to severe dehydration. Viral hepatitis (HAV, HBV, HCV) causes acute and chronic liver damage, managed through vaccination or antiviral therapies. Lastly, HIV infection weakens the immune system, exposing patients to opportunistic infections, but is managed as a chronic disease using antiretroviral therapy (ART).

References

Durand ML, Calderwood SB, Weber DJ, Miller SI et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993;328:21–8.

Scheld WM, Koedel U, Nathan B, Pfister HW. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. Review. J Infect Dis 2002;186(Suppl 2): S225–33.

Health Protection Agency Communicable Disease Surveillance Centre. Statutory Notifications of Infectious Diseases in England and Wales (NOIDS). Availeble at www.hpa.org.uk/infections/topics_az/noids /menu.htm

Data from World Health Organisation, Hib-Paediatric Bacterial Meningitis Surveillance Network Overview. Availeble at www.afro.who.int/hib/

Hasbun R, Abrahams J, Jekel J, Quagliarello VJ. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 2001;345: 1727–33.

Corless CE, Guiver M, Borrow R, Edwards-Jones V et al. Simultaneous detection of Neisseria Meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol 2001;39:1553–8.

Schut ES, Lucas MJ, Brouwer MC, Vergouwen MD, van der Ende A, van de Beek D. Cerebral infarction in adults with bacterial meningitis. Neurocrit Care 2012; 16:421-7.

Zekaver odabaşı. Yoğun Bakım Dernegi Dergisi, 2005;(3):1.

Willke Topçu A, Söyletir G, Doğanay M. Editörler. Enfeksiyon Hastalıkları Kitabı. Nobel Tıp Kitapevleri 2002; 1029–41.

Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison’s Principles of Intemal Medicine. 13 th ed. McGraw-Hill: 1994.

de Gans J, van de Beek D, European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002;347(20):1549-56

Marconi VC, Garcia HH, Katz JT. Neurocysticercosis. Curr Infect Dis Rep 2006; 8:293–300.

Johnson RH, Einstein HE. Coccidioidal meningitis. Clin Infect Dis 2006; 42:103–7.

Williams PL. Coccidioidal meningitis. Ann NY Acad Sci 2007; 1111:377–84.

Thwaites, C.L.; Yen, L.M.; Loan, H.T.; Thuy, T.T.;Thwaites, G.E.; Stepniewska, K.; Soni, N.; White, N.J.; Farrar, J.J. Magnesium sulphate for treatment of severe tetanus: A randomised controlled trial. Lancet 2006, 368, 1436–1443.

Thwaites, C.L.; Yen, L.M.; Cordon, S.M.; Thwaites, G.E.; Loan, H.T.; Thuy, T.T.; White, N.J.; Soni, N.; Macdonald, I.A.; Farrar, J.J. Effect of magnesium sulphate on urinary catecholamine excretion in severe tetanus. Anaesthesia 2008, 63, 719–725.

Aguiler Bernal, O.R.; Bender, M.A.; Lacy, M.E. Efficacy of dantrolene sodium in management of tetanus in children. J. R. Soc. Med. 1986, 79,277–281.

Restivo, D.A.; Marchese-Ragona, R. Botulinum toxin treatment for oropharyngeal dysphagia due to tetanus. J. Neurol. 2006, 253, 388–389.

Sharma, A.; Malhotra, S.; Grover, S.; Jindal, S.K. Incidence, prevalence, risk factor and outcome of delirium in intensive care unit: A study from India. Gen. Hosp. Psychiatry 2012, 34, 639–646.

Lambo, J.; Khahro, Z.; Memon, M.; Lashari, M. Neonatal tetanus incidence in Dadu District, Pakistan, 1993–2003. Scand. J. Infect. Dis. 2011, 43, 175–180.

Van den Berg, J.P.; Westerbeek, E.A.; Berbers, G.A.; van Gageldonk, P.G.; van der Klis, F.R.; van Elburg, R.M. Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, haemophilus influenzae type b, and Neisseria meningitidis serogroup C is lower in preterm compared with term infants. Pediatr. Infect. Dis. J. 2010, 29, 801–805.

Geeta, M.G.; Krishnakumar, P.; Mathews, L. Intrathecal tetanus immunoglobülins in the management of tetanus. Indian J. Pediatr. 2007, 74, 43–45.

Chukwubike, O.A.; God’spower, A.E. A 10-year review of outcome of management of tetanus in adults at a Nigerian tertiary hospital. Ann. Afr. Med. 2009, 8, 168–172.

Azher, S.N.; Jankovic, J. Camptocormia: Pathogenesis, classification, and response to therapy. Neurology 2005, 65, 355–359.

Lim, E.C.; Seet, R.C. Botulinum toxin injections to treat belly dancer’s dyskinesia. Mov. Disord. 2009, 24, 1401.

Jabbari, B. Evidence based medicine in the use of botulinum toxin for back pain. J. Neural. Transm. 2008, 115, 637–640.

Marik, P.E. Propofol: Therapeutic indications and side-effects. Curr. Pharm. Des. 2004, 10, 3639 3649.

Blitzer, A. Botulinum toxin A and B: A comparative dosing study for spasmodic dysphonia. Otolaryngol. Head Neck Surg. 2005, 133, 836–838.

Bingham J, Van Der Merwe M. Distribution of rabies antigen in infected brain material: determining the reliability of different regions of the brain for the rabies fluorescent antibody test. J Virol Methods 2002;101:85–94.

Catherine M, Brown CM, DeMaria A. When to use rabies prophylaxis. Erişim:16 Ocak 2019. Erişim adresi: https://www.uptodate.com/contents/when-to-userabies-prophylaxis.

World Organisation For Animal Health. Rabies (infection with Rabies Virüs) and other Lyssa-virüs. OIE Terrestial Manual 2018. Erişim tarihi: 12 Ocak 2019. Erişim adresi: http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2.01.17_RABIES.pdf

Charles E. Rupprecht CE, Abela-Ridder B, Fooks AR. Laboratory techniques in rabies. 5th edition. World Health Organization 2018. WHO reference number: WHO/CDS/NTD/NZD/2018.03.

De Serres G, Skowronski DM, Mimault P, et al. Bats in the bedroom, bats in the belfry: reanalysis of the rationale for rabies postexposure prophylaxis. Clin Infect Dis 2009; 48:1493-9.

Denis M, Knezevic I, Wilde H, Hemachudha T, Briggs D, Knopf L. An overview of the immuno-genicity and effectiveness of current human rabies vaccines administered by intradermal route. Vaccine 2018. doi: 10.1016/j.vaccine.2018.11.072.

Huang G, Liu H, Cao Q, Liu B, Pan H, Fu C. Safety of post-exposure rabies prophylaxis during pregnancy: a follow-up study from Guangzhou, China. Hum Vaccin Immunother 2013; 9:177–83.

Kan VL, Joyce P, Benator D, et al. Risk assessment for healthcare workers after a sentinel case of rabies and review of the literature. Clin Infect Dis 2015; 60:341-8.

King A, Turner GS. Rabies: A Review. J Comp Path 1993;108:1-39. 22. Lang L, Feroldi E, Vien NC. Pre-exposure purified vero cell rabies vaccine and concomitant routine childhood vaccinations: 5-year post-vaccination follow-up study of an infant cohort in Vietnam J Trop Pediatr 2009; 55:26-31.

Langedijk AC, De Pijper CA, Spijker R, Holman R, Grobusch MP, Stijnis C. Rabies antibody response after booster immunization: a systematic review and metaanalysis.Clin Infect Dis 2018; 67:1932-47.

Mani RS, Madhusudana SN. Laboratory diagnosis of human rabies: recent advances. Scientific World J 2013;569712.

Manning SE, Rupprecht CE, Fishbein D, et al. Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2008; 57(RR-3):1-28.

Centers for Disease Control and Prevention. Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices. Centers for Disease Control and Prevention. MMWR 2010;59(RR02):1-9. Erişim tarihi: 12.12.2018. Erişim adresi: https://www.cdc.gov/MMWR/Preview/ MMWRhtml/rr5902a1.htm.

Ross RS, Wolters B, Hoffmann B, et al. Instructive even after a decade: Complete results of initial virological diagnostics and re-evaluation of molecular data in the German rabies virüs “outbreak” caused by transplantations. Int J Med Microbiol 2015; 305:636-43.

Rupprecht CE, Briggs D, Brown CM, et al. Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals. Vaccine 2009; 27:7141-8.

Sari T, Tulek N, Bulut C, Oral B, Tuncer Ertem G. Adverse events following rabies post-exposure prophylaxis: a comparative study of two different schedules and two vaccines.Travel Med Infect Dis 2014;12:659-66.

Suggested Reading Cheng A, McDonald J, Thielman N. Infectious diarrhea in developed and developing countries. Journal of Clinical Gastroenterology. 2005;39:757–773.

Clark B, McKendrick M. A review of viral gastroenteritis. Current Opinion in Infectious Diseases. 2004;17:461–469.

Diagnosis and Management of Foodborne Illnesses: A Primer for Physicians MMWR. 2001;50(RR02):1-69.

Accessed from http://www.cdc.gov/mmwr/pre-view/mmwrhtml/rr5002a1.htm on 8/16/2006.

Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clinical Infectious Diseases 2001;32:331–351.

Ilnyckyj A. Clinical evaluation and management of acute infectious diarrhea in adults. Gastroenterology Clinics of North America. 2001;30:599–609.

Musher D, Musher B. Contagious acute gastrointestinal infections. The New England Journal of Medicine. 2004;351:2417–2327.

Lodfield E, Wallace M. The role of antibiotics in the treatments of infectious diarrhea. Gastroenterology Clinics of North America. 2001;30:817–835.

Roe A, Gally D. Enteropathogenic and enterohaemorrhagic Escherichia coli and diarrhoea. Current Opinion in Infectious Diseases. 2000;13:511–517.

Su C, Brandt L. Escherichia coli 0157:H7 infection in humans. Annals of Internal Medicine. 1995;123:698–707.

Turgeon D, Fritsche T. Laboratory approaches to infectious diarrhea. Gastroenterology Clinics of North America. 2001;30:693–707.

Ghany MG, Kiang TJ. Acute viral hepatitis. In: Textbook of Gastroenterology. 4th ed. Philedelphia: Lippincott Williams and Wilkins, 2003:2276–2301.

Leach CT. Hepatitis A in the United States. Pediatr Infect Dis J 2004;23:551–552.

Rawls RA, Vega KJ. Viral hepatitis in minority America. J Clin Gastroenterol 2005;39:144–151.

Fox RF, Wright TL. Viral hepatitis. In: Current Diagnosis and Treatment in Gastroenterology. 2nd ed. New York: McGraw-Hill, 2003:545–562.

Craig AS, Schaffner W. Prevention of hepatitis A with the hepatitis A vaccine. N Engl J Med 2004;350:476–481.

Campos-Outcalt D. Hepatitis A: matching preventive resources to needs. J Fam Prac 2004;53:292–295. 7.

Giboney PT. Mildly elevated liver transaminase levels in the asymptomatic patient. Am Fam Phy 2005;71:1105–1110.

CDC. Sexually transmitted diseases treatment guidelines. MMWR 2002:51:59–66.

CDC. Recommendation of the Immunization Practices Advisory Committee (ACIP). A comprehensive immunization strategy to eliminate transmission of hepatitis B virüs infection in the United States. MMWR 2005;54(RR16):1–23.

Ganem D, Prince AM. Hepatitis B virüs infection—natural history and clinical consequences. N Engl J Med 2004;350:1118–1129.

Crockett SD, Keeffe EB. Natural history and treatment of hepatitis B virüs and hepatitis C virüs coinfection. Ann Clin Micro Antimicrobials 2005;4:13.

CDC. Hepatitis C fact sheet. 2005. Available at http://www.cdc.gov/hepatitis.

Management of hepatitis C:2002. NIH Consens State Sci Statement 2002;19:1–46.

Kim AI, Saab S. Treatment of hepatitis C. Am J Med 2005;118:080–815.

Wong T, Lee SS. Hepatitis C: a review for primary care physicians. CMAJ 2006;174: 649–659.

Ward RP, Kugelmas M, Libsch KD. Management of hepatitis C: evaluating suitability for drug therapy. Am Fam Physician 2004;69:1429–1438.

Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003;362:2095–2100.

Taylor JM. Hepatitis delta virüs. Virology 2006;344:71–76.

Niro GA, Rosina F, Rizzetto M. Treatment of hepatitis D. J Vir Hep 2005;12:2–9. 23. Wang L, Zhuang H. Hepatitis E: an overview and recent advances in vaccine research. World J Gastroenterol 2004;10:2157–2162.

Guidelines for the Use of Antiretroviral Agents in Pediatric HİV Infection. Oct 26, 2006; 1–126. Availeble at: http://www.aidsinfo.nih.gov/Contentfiles/PediatricGuidelines.pdf.

Perinatal HİV Guidelines Working Group. Public Health Service Task Force Recommendations for the Use of Antiretroviral Drugs in Pregnant HİV-1 Infected Women for Maternal Health and Interventions to Reduce Perinatal HİV Transmission in the United States. Nov 2, 2007; 1–101. Availeble at: http://www.aidsinfo. nih.gov/Contentfiles/PerinatalGL/pdf.

R. Harris Association/Infectious Disease Society of America. December 17, 2004;1–135. Availeble at: http://www.aidsinfo.nih.gov/contentfiles/TreatmentofOI_AA.pdf.

Updated US Public Health Service Guidelines for the Management of Occupational Exposures to HİV and Recommendations for Post-Exposure Prophylaxis. MMWR Sept 30, 2005;54 (RR09):1–17.

Antiretroviral post-exposure prophylaxis after sexual, injection drug use, or other non-occupational exposures to HİV in the US. MMWR Jan 21, 2005;54(RR02):1–20.

Cases of HİV infection and AİDS in the United States and dependent areas 2005. Availeble at http://www.cdc.gov/HİV/topics/surveillance/basic.htm.

Revised Classification System for HİV Infection and Expanded Surveillance Case Definition for AİDS Among Adolescents and Adults. MMWR Dec 18, 1992;41(RR 17). Availeble at: http://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm.

Guidelines for the use of antiretroviral drugs in HİV-infected adults and adolescents. Department of Health and Human services. Dec 1, 2007.

Published

January 5, 2022

License

License